Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohnʼs disease of the colon
Open Access
- 1 April 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 15 (4) , 630-638
Abstract
To minimize the possibility of developing lethal colorectal cancer (CRC) in ulcerative colitis (UC) and Crohn's colitis, patients are usually enrolledKeywords
This publication has 86 references indexed in Scilit:
- Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort StudyGastroenterology, 2007
- Pathology of Dysplasia and Cancer in Inflammatory Bowel DiseaseGastroenterology Clinics of North America, 2006
- Chemoprevention: Risk Reduction with Medical Therapy of Inflammatory Bowel DiseaseGastroenterology Clinics of North America, 2006
- Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease2006
- ReplyGastroenterology, 2004
- Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease2004
- Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidenceGastroenterology, 2003
- Low-Grade Dysplasia in Extensive, Long-Standing Inflammatory Bowel DiseaseDiseases of the Colon & Rectum, 2002
- Cancer in Crohn's disease: dispelling the myths.Gut, 1994
- Increased risk of large-bowel cancer in Crohn's disease with colonic involvementThe Lancet, 1990